Sung Lab

Anthony D. Sung, MD, Primary Investigator

Anthony D. Sung, MD

Assistant Professor of Medicine
Member of the Duke Cancer Institute
 

Education

Fellowship, Hematology Oncology, Duke University School of Medicine, 2011 - 2014
Residency, Osler Medical Housestaff Training Program, Johns Hopkins University School of Medicine, 2008 - 2011
M.D., Harvard University , 2008

Research in the Sung lab focuses on strategies to reduce complications of HCT and ranges from preclinical studies using murine models of HCT to Phase 1 and Phase 2 clinical trials.

Lab Members

Megan Covington
Lab Research Analyst, Senior

Amy Bush 
Lab Research Analyst I

Shara Reihani
Research Program Leader, Sr

Lauren Hill
Research Program Leader

Hilary Winthrop
Clinical Research Coordinator, Tier 2

Andrea Pires
Clinical Research Coordinator, Tier 1

Ernaya Johnson
Clinical Research Specialist, Sr

Yi Ren
Biostatistician III

Ashley Artese
Postdoctoral Scholar

John Bokman
Research Technician II

Current Studies

I am dedicated to the treatment of hematologic malignancies through cellular therapies such as hematopoietic stem cell transplantation (HCT). My research focuses on strategies to reduce complications of HCT and ranges from preclinical studies using murine models of HCT to Phase 1 and Phase 2 clinical trials. Areas of interest include the role of the microbiota (the trillions of bacteria living in and on our bodies), nutrition, and exercise in modulating HCT outcomes such as graft-versus-host disease (GVHD) and infections. In addition to advancing new pharmacological and cellular immunotherapies in support of these goals, we also are developing mobile health technologies (mHealth) to monitor patients at home, both as part of our innovative home transplant program as well as to improve follow up care of all our patients when they return home after transplant.